As of May 28, 2025, Immunodiagnostic Systems Holdings PLC (IDH.L) reports a EV/EBITDA of N/A.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Immunodiagnostic Systems Holdings PLC's EV/EBITDA to Peers
To better understand Immunodiagnostic Systems Holdings PLC's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Immunodiagnostic Systems Holdings PLC (IDH.L) | - |
| Biocorp Production SA (ALCOR.PA) | 4335.46 |
| Bluelinea SA (ALBLU.PA) | 434.66 |
| Nexstim Oyj (NXTMH.HE) | 179.53 |
| ScandiDos AB (SDOS.ST) | 48.69 |
| Medicon Hellas SA (MEDIC.AT) | 45.71 |
Compared to its competitors, Immunodiagnostic Systems Holdings PLC's EV/EBITDA is difficult to compare due to insufficient data.